Safety and Efficacy Evaluation of Next-generation CD19-UCART
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Acute Lymphoblastic Leukemia
Related studies linked through entity extraction aliases.
European Prospective Investigation Into Childhood Cancer
- Status
- RECRUITING
- Phase
- N/A
Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents
- Status
- RECRUITING
- Phase
- PHASE2
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Status
- RECRUITING
- Phase
- N/A
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
- Status
- RECRUITING
- Phase
- PHASE3
Effect of Metformin on ABCB1 and AMPK Expression in Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia
- Status
- UNKNOWN
- Phase
- NA
The Patient Cohort of the National Center for Precision Medicine in Leukemia
- Status
- RECRUITING
- Phase
- N/A
A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias
- Status
- WITHDRAWN
- Phase
- PHASE1
A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Residual Disease Driven Strategy for CARCIK (CD19) in Adults/Pediatric BCP-ALL
- Status
- UNKNOWN
- Phase
- PHASE2
To Evaluate the Safety and Tolerability of Human CD19-CD22 Targeted T Cells Injection for Subjects With R/R B-ALL.
- Status
- UNKNOWN
- Phase
- PHASE1
CD19- and CD22-directed CAR-T Cell Therapy in Patients With Acute Lymphoblastic Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL
- Status
- TERMINATED
- Phase
- PHASE1
90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE4
A Phase 1b-2 Trial to Assess Venetoclax and Navitoclax Consolidation and Post-transplant Maintenance in High-risk Patients With T-ALL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Programmed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Two Step Haplo With Radiation Conditioning
- Status
- RECRUITING
- Phase
- PHASE2